Last updated: 7 months ago
Lyell Immunopharma 8-K/A Report: Key Updates for Investors (LYEL)
Lyell Immunopharma, Inc. filed an 8-K/A on October 31, 2024, revealing significant updates. Discover crucial insights about their financials and corporate developments.